地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18327026838
邮箱:sales@amyjet.com

Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |
<艾美捷科技代理AkrivisBio品牌全系列产品
AkrivisBio是生命科学与生物技术领域的研究产品供应商,公司名"Akrivis"源自古希腊语,意为"精准",彰显企业核心理念;"Bio"则界定我们其专业领域。AkrivisBio公司的核心产品线包括细胞增殖与毒性检测平台、代谢分析系统、样品分离与制备试剂盒、专业染色试剂盒以及生化试剂系列。

▎AkrivisBio产品线
●检测试剂盒(部分产品列表)
①细胞增殖与毒性检测:AkrivisBio公司提供多种细胞毒性及增殖检测方案,包括用于药物筛选的MTT法、MTS法和LDH检测法。我们的试剂盒操作简单、高效便捷,可兼容多种样本类型。
②代谢分析:AkrivisBio公司提供涵盖碳水化合物代谢、脂质代谢、氨基酸合成等多条通路的代谢检测试剂盒,用于精准定量代谢物、分析物及中间产物。试剂盒具有精度高、速度快、操作简便等优势,适用于各类样本,并兼容酶标仪、荧光酶标仪及分光光度计等常用检测设备。
③样品分离与制备试剂盒:产品线包含:细胞器分离富集试剂盒(线粒体、溶酶体等)、细胞组分分离试剂盒(细胞核、胞质蛋白、膜蛋白等)、以及TCA/PCA/SSA去蛋白试剂盒(用于分析前去除样本蛋白质)。这些试剂盒提供便捷高效的样本处理方案,分离后的样本可完美适配Western blot等下游应用。
④染色试剂盒:通过特异性染料或抗体标记目标分子,实现DNA、蛋白质、脂质、细胞器及特定标志物的可视化观测。AkrivisBio公司提供脂质染色试剂盒、细胞活性/毒性双染试剂盒、β-半乳糖苷酶染色试剂盒等系列产品,满足各类研究需求。
| 品名 | 货号 | Size |
| LDH Based Cell Cytotoxicity Assay | CPT-0101 | Includes reagents for 500 wells |
| Crystal Violet Cell Cytotoxicity Assay | CPT-0102 | Includes reagents for 1000 wells |
| MTT Cell Proliferation Assay | CPT-0103 | Includes reagents for 1000 wells |
| MTS Cell Proliferation Assay | CPT-0104 | Includes reagents for 2500 wells |
| Quick Cell Proliferation Assay | CPT-0105 | Includes reagents for 500 and 2500 wells |
| Ready-to-use Cell Proliferation Reagent | CPT-0106 | Includes reagents for 2500 wells |
| Neutral Red Cell Cytotoxicity Assay | CPT-0107 | Includes reagents for 1000 wells |
| Oil Red O Lipid Staining Kit | COS-0101 | To stain two plates (6- 12-, 24- or 96-well) or five 100 mm culture dishes |
| Senescence Staining Assay | COS-0102 | To stain 4X 24-, 12-, 6-well plates |
| Live vs. Dead Cell Differentiation Staining Kit | COS-0103 | Includes reagent for staining 4 x 24-well plates. |
| Beta-galactosidase Staining Kit | COS-0104 | Includes reagents to stain 20 x 12-well plates or the equivalent volume of 6 or 24-well plates. |
| Alkaline Phosphatase Staining Kit | COS-0105 | Includes reagents to stain 96-, 48-, 24-, 12-, 6-well plates |
| Cell-Based Lysosomal Cytotoxicity Dual Staining Kit | COS-0106 | 50 assays |
| CaspACTIV Active Caspase-9 Staining Kit | COS-0107 | 25 wells, 100 wells |
| Annexin V-FITC Apoptosis Detection Kit | COS-0108 | 25 wells, 100 wells |
| Protein Myristoylation Assay | COS-0109 | 100 wells |
●即用型微孔板
| 品名 | 货号 | Size |
| Glucose RediPlate | RP-0122C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Pyruvate Kinase RediPlate | RP-0107C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Alkaline Phosphatase Activity Assay | RP-0109C | 480 wells |
●生化试剂(部分产品列表)
| 品名 | 货号 | CAS号 | 分子式 |
| 2-Hexyl-4-Pentynoic Acid | B2834 | 96017-59-3 | C₁₁H₁₈O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Destruxin A | B2947 (Copy) | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| DTBA | B3242 | 1363376-98-0 | C₄H₁₁NS₂·HCl |
| Telotristat | B338 | 1033805-28-5 | C₂₅H₂₂ClF₃N₆O₃ |
| AZD-4573 | B3319 | 2057509-72-3 | C₂₂H₂₈ClN₅O₂ |
| Eltoprazine hydrochloride | B2301 | 98206-09-8 | C₁₂H₁₆N₂O₂HCl |
| 3-TYP | B2322 | 120241-79-4 | C₇H₆N₄ |
| LY-2510924 | B2360 | 1088715-84-7 | C₆₂H₈₇N₁₃O₁₁ |
| Salermide | 1873 | 1105698-15-4 | C₂₆H₂₂N₂O₂ |
| Atractyloside Potassium Salt | B2441 | 102130-43-8 | C₃₀H₄₄K₂O₁₆S₂ |
| PZ-2891 | B2460 | 2170608-82-7 | C₂₀H₂₃N₅O |
| Lanreotide Acetate | B2464 | 127984-74-1 | C₅₄H₆₉N₁₁O₁₀S₂ · xC₂H₄O₂ |
| Vesatolimod | B2555 | 1228585-88-3 | C₂₂H₃₀N₆O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Sodium dichloroacetate | B3080 | 2156-56-1 | C₂HCl₂NaO₂ |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Pibrentasvir | B2168 | 1353900-92-1 | C₅₇H₆₅F₅N₁₀O₈ |
| STF-62247 | B2210 | 315702-99-9 | C₁₅H₁₃N₃S |
| Anastrozole | B2177 | 120511-73-1 | C₁₇H₁₉N₅ |
<艾美捷科技代理Lifeome品牌全系列产品
Lifeome公司致力于基因组学、转录组学及蛋白质组学领域的产品研发、生产与市场化,提供全方位的研究产品与服务体系。Lifeome核心产品包括生长因子、抗体、病毒蛋白、重组蛋白,基因工程克隆载体等。
▍Lifeome公司的服务
● 定制抗体开发服务:多克隆与单克隆抗体解决方案,应用于蛋白定量检测、细胞/组织定位分析(活体或固定样本),由政府认证实验室提供全流程生产服务;
● 高端多肽合成解决方案:由平均从业5年以上的技术专家操作顶级合成系统,覆盖从基础科研到工业级生产需求;
● 蛋白质表达与纯化:其培养简便、产量高,能快速获得免疫原。

| Cytokines | ||||
| Bone Morphogenetic Protein | Beta Defensin | Endoglin | Interleukin | Serum Amyloid A |
| Leukemia Inhibitory Factor | Betacellulin | Flt3 Ligand | Apoliproteins | Thrombopoietin |
| B Cell Activating Factor | Angiopoietin | Hedgehog Progein | Others | Trefoil Factor |
| B type Natriuretic Peptide | EBI3 | Interferon | Resistin | Visfatin |
| Tumor Necrosis Factor | ||||
| Chemokines | ||||
| ENA 78 | IL-8 (CXCL8) | MDC (CCL22) | NAP-2 (CXCL7) | SDF (CXCL12) |
| Lymphotactin (XCL1) | IP-10 (CXCL10) | MEC (CCL28) | Others | TARC (CCL17) |
| Platelet Factor-4 (CXCL4) | Eotaxin | MIG (CXCL9) | GRO | Rantes (CCL5) |
| I-TAC (CXCL11) | MCP | MIP | ||
| Recombinant Proteins | ||||
| ADP-Ribosylation Factor | Cardiac Troponin | Superoxide Dismutase | Profilin | Streptavidin |
| Synaptosomal Associated Protein | Chromogranin | Hypoxia-Inducible Factor | BID | HSP |
| TNF receptor-Associated Factor | cJun | U6 Small Nuclear RNA | Protein-A, A/G & G | Synaptobrevin |
| Microtubule-Associated Protein | Annexin | Melanoma Antigen | RAS Oncogene | Albumin |
| Myelin Oligodendrocyte GlycoP | Aprotinin | Coaggulation Factors | Calbindin | Syndecan |
| Translation Initiation Factors | Collagen | Coagulation Factors | Cell Division Cycle | Synuclein |
| B Cell Lymphoma | Crystallin | Myoglobin | Centromere Protein | Thioredoxin |
| Beta 2 Microglobulin | Cystatin | Myosin Light Chain | Ribosomal Protein | Thrombin |
| Programmed Cell Death | Cytokeratin | DNA-Damage Protein | Secretagogin | Allergy |
| C-Reactive Protein | Nanog | Natural Proteins | Selectin | Transferrin |
| Ras-Related C3 Botulinum Tox... | Dynein Light Chain | Non-Metastatic Cells | Septin | Transgelin |
| Calcium Binding Protein | Ephrin | Visinin-Like Protein | Serpin | Avidin |
| Small Nuclear Ribonucleo... | ER Proteins | Outer Membrane Protein | CD Antigens | Tropomyosin |
| Chloride Intracellular Channel | FABP | p53 | Sirtuin | Trypsin |
| Sex Determining Region Y Box | Ferritin | PCNA | SMAD | Killer Cell |
| Regenerating Islet-Derived | Fibronectin | POU Class | Calmodulin | Ubiquitin |
| Regulator of G-Protein Signaling | Prefoldin | High-Mobility Group | Stathmin | Vimentin |
| Antibodies | ||||
| Anti Human Chemokine | Anti Viral | Anti Human Cytokine | Anti Human Enzymes | Anti Human HSP |
| Anti Human Lymphocyte | ELISA Pairs | Anti Mouse Lymphocyte | Anti Expression Tags | Anti Mouse Cytokine |
| Polyclonal Rabbit Antibodies | Rare Antibodies | |||
| Viral Proteins | ||||
| Borrelia | EBV | Hepatitis C | Malaria | Rubella |
| Chagas | Encephalitis | Hepatitis D | Measles | S. Typhi |
| Chikungunya | West Nile | Hepatitis E | Mumps | SARS |
| Chlamydia | Hantavirus | Herpes | Mycoplasma | Shiga Like Toxin |
| Cytomegalo | HBsAg | HIV | Norovirus | Toxoplasma |
| Dengue | Hepatitis A | HTLV | Papillomavirus | Treponema |
| Ebola | Hepatitis B | Influenza | Parvovirus | Varicella |
| Feline Leukemia Virus | Zika | |||
| Growth Factors | ||||
| Melanoma Inhibitory Proteins | Galectin | Keratinocyte GF | Omentin | Prolactin |
| Colony Stimulating Factor | Growth Hormone | Leptin | Oncostatin-M | RANK Ligand |
| Hepatocyte Growth Factor | CTGF | Macrophage Migration IF | Osteoprotegerin | Retinol Binding P |
| Epidermal Growth Factor | IGFBP | Activin | Others | Stem Cell Factor |
| Transforming Growth Factor | Insulin | Myostatin | PDGF | Erythropoietin |
| Fibroblast Growth Factor | Insulin-like GF | Noggin | Placental Lactogen | VEGF |
| Research Reagents | ||||
| Biochemical Kits | CoVID19 | CRISPR-Cas9 | Media/Plates | Molecular Markers |
| Nucleic Acids Purification | Seamless Cloning | |||
| Primary Cells | ||||
| Dog | Goat | Mouse | Rabbit | Rat |
| ELISA | ||||
| Chemiluminescent | HRP | Specialty Kits | ||
| Xpress Clones | - | cis Element Reporter | ||
| Bacterial Clones | Mammalian Clones | - | Hygromycin Kits | Neomycin Kits |
▍Lifeome部分产品列表
<| 品名 | 货号 | 规格 |
| Primary AC Cell, Dog | CSI003Ca01-500k | 5x10^5 |
| Primary AEC Cell, Dog | CSI006Ca01-500k | 5x10^5 |
| Primary AFC Cell, Dog | CSI008Ca01-500k | 5x10^5 |
| Primary ASMC Cell, Dog | CSI153Ca01-500k | 5x10^5 |
| Primary BMMC Cell, Dog | CSI164Ca01-500k | 5x10^5 |
| Primary BMMSCs Cell, Dog | CSI083Ca01-500k | 5x10^5 |
| Primary MC Cell, Dog | CSI007Ca01-500k | 5x10^5 |
| Primary NDF Cell, Dog | CSI088Ca01-500k | 5x10^5 |
| Primary NPC Cell, Dog | CSI113Ca01-500k | 5x10^5 |
| Primary OB Cell, Dog | CSI102Ca01-500k | 5x10^5 |
| Primary OF Cell, Dog | CSI138Ca01-500k | 5x10^5 |
| Primary RCEC Cell, Dog | CSI067Ca01-500k | 5x10^5 |
| Primary SEC Cell, Dog | CSI112Ca01-500k | 5x10^5 |
| Primary TDSC Cell, Dog | CSI255Ca01-500k | 5x10^5 |
| Primary TSMC Cell, Dog | CSI068Ca01-500k | 5x10^5 |
| Primary AC Cell, Goat | CSI003Cp01-500k | 5x10^5 |
| Primary ASMC Cell, Goat | CSI153Cp01-500k | 5x10^5 |
| Anti-APOB100 Antibody | A90603Hu01-1 | 100 ug |
| Anti-APOC2 Antibody | PAB77963-1 | 100 ug |
| Anti-HPR Antibody | A92000Hu01-1 | 100 ug |
| Antibody to Mouse Insulin (INS) | A90448Mu01-100ug | 100 ug |
| Antibody to Mouse Insulin (INS) | A90448Mu01-50ug | 50 ug |

艾美捷科技代理NeXtal Biotechnologies品牌。
NeXtal Biotechnologies 是一家专注于为结构生物学和药物发现领域提供高质量试剂、耗材和工具的公司。公司致力于支持科学家在蛋白质晶体学、小分子晶体学和药物筛选等领域的研究,提供从蛋白质纯化到晶体生长的全流程解决方案。NeXtal Biotechnologies核心业务领域:
(1)蛋白质纯化工具:NeXtal Biotechnologies 提供用于蛋白质纯化的工具和试剂,如亲和层析柱、蛋白质浓缩器和透析设备。
(2)晶体生长试剂:公司提供多种用于蛋白质和小分子晶体生长的试剂,包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。
(3)结晶筛选试剂盒:NeXtal Biotechnologies 提供多种结晶筛选试剂盒,如 JCSG+、Morpheus 和 PACT,适用于不同类型的晶体生长实验。
(4)晶体学耗材:提供用于晶体学研究的耗材,如结晶板、密封膜、样品支架和低温冷冻工具。这些耗材与主流X射线衍射仪兼容,支持从晶体生长到数据收集的全流程。
(5)自动化晶体成像系统:NeXtal Biotechnologies 提供自动化晶体成像系统(如 Rock Imager),用于实时监测晶体生长过程,帮助科学家优化晶体生长条件。
(6)药物筛选工具:公司提供用于药物筛选的工具和试剂,如蛋白质-配体结合分析试剂盒和高通量筛选板。
< " data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理NeXtal Biotechnologies品牌"> 艾美捷科技代理NeXtal Biotechnologies品牌

艾美捷科技代理Cali-Bio品牌。
Cali-Bio成立于 2009 年,总部位于美国加利福尼亚州,是一家专注于为生命科学研究和生物制药行业提供高质量试剂、细胞培养工具和相关服务的公司。Cali-Bio公司专注于开发和生产高质量的生物试剂和细胞培养工具,产品涵盖细胞培养基、血清、生长因子、细胞分离试剂和定制服务等。Cali-Bio 的产品被广泛应用于细胞生物学、免疫学、癌症研究、干细胞研究和生物制药等领域。Cali-Bio公司主要产品包括:
(1)细胞培养基
经典培养基,提供 DMEM、RPMI-1640、MEM 等常用培养基。
无血清培养基,适用于特定细胞类型的无血清培养,减少批次间差异。
干细胞培养基,支持干细胞的自我更新和分化。
(2)血清和补充剂
胎牛血清(FBS),高质量胎牛血清,适用于多种细胞培养。
马血清、人血清,用于特定细胞类型的培养。
生长因子和细胞因子,包括 EGF、FGF、IGF 等,支持细胞生长和功能维持。
(3)细胞分离和传代试剂
胰酶和细胞解离试剂,用于细胞传代和单细胞分离。
细胞冻存液,提供高效的细胞冻存解决方案,确保细胞存活率。
(4)细胞检测和分析工具
细胞活力检测试剂,如 MTT、CCK-8 等,用于评估细胞活力和增殖。
细胞凋亡检测试剂,用于检测细胞凋亡和坏死。
细胞迁移和侵袭实验试剂,支持癌症研究和药物筛选。

艾美捷科技代理ImmunoStep品牌。
ImmunoStep是一家专注于流式细胞术和免疫学研究的生物技术公司,主要提供高质量的试剂和工具,支持免疫表型分析、细胞功能研究和临床诊断。ImmunoStep公司的产品与服务包括:
(1)流式细胞术试剂:
抗体:提供多种荧光标记的单克隆抗体,适用于人、小鼠、大鼠等物种。
染色缓冲液:优化细胞染色过程。
细胞活力染料:用于区分活细胞和死细胞。
(2)试剂盒:
免疫表型分析试剂盒:用于快速、多参数分析免疫细胞亚群。
细胞因子检测试剂盒:用于检测细胞内或分泌的细胞因子。
(3)定制服务:
抗体标记:根据客户需求定制荧光标记抗体。
面板设计:帮助客户设计多色流式细胞术实验面板。
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理ImmunoStep品牌"> 艾美捷科技代理ImmunoStep品牌
艾美捷科技代理KRISHGEN BioSystems品牌ELISA试剂盒。
凭借在免疫学方面的深厚背景,KRISHGEN BioSystems提供经过充分验证的高质量检测试剂盒、试剂和耗材。
(1)产品分类:
抗药物抗体/免疫原性ELISA
双特异性抗体药物ELISA
融合蛋白ELISA
单克隆抗体药物中和抗体ELISA
肽药物抗体/肽抗体ELISA
跨膜蛋白质ELISA
基于TDM/MAb的生物类似物ELISA
宿主细胞蛋白ELISA
宿主细胞DNA污染检测
DsRNA检测ELISA
生物过程抗生素残留ELISA
生物过程残留物ELISA
专业凝血酶测定ELISA
生物标志物ELISA
(2)热门研究领域包括:
肿瘤学:肿瘤标志物和相关单克隆/双特异性抗体药物的特异性ELISA;
神经变性:神经变性标志物和相关mAb药物的特异性ELISA;
炎症:炎症和过敏标志物、细胞因子和相关单克隆抗体药物的特异性 ELISA;
糖尿病/代谢:代谢通路标志物和糖尿病生物类似药的特异性ELISA。
< " data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理KRISHGEN BioSystems品牌"> 艾美捷科技代理KRISHGEN BioSystems品牌
艾美捷科技代理Ligatrap品牌全系列产品
LigaTrap Technologies是一家位于北卡罗来纳州的创新型生物技术公司,提供独特的专利技术组合,专注于蛋白质纯化领域。LigaTrap精于抗体与病毒纯化,服务于抗体药物、病毒疫苗及基因治疗产业。
▍LigaTrap公司产品
● LigaGuard:最新推出的亲和吸附剂,是由多模态配体构成的专利复合体系,可在流穿模式(连续流)下选择性捕获宿主细胞蛋白(HCPs)与DNA。
● AAVidity™:一种新型亲和层析填料,用于血清型普适性纯化 源自 HEK293 和 Sf9 细胞裂解液 的 腺相关病毒(AAV)。
● IgM Resin:专为纯化 IgM 抗体设计的亲和树脂,具有高纯度、高结合能力、温和的洗脱条件(pH 约 4.0),并可重复使用多达 100 次。
● Base Resin:专为从多克隆与单克隆来源中纯化高质量抗体而设计,该树脂推荐用于纯化:多种物种的 IgG(包括人、小鼠、兔等);人源 IgA;鸡源 IgY。
● LigaTrap Buffers:包含Regeneration Buffer,Neutralization Buffer,Elution Buffer,Regeneration Buffer,Equilibration/Wash Buffer 2.0等。

▍LigaGuard
LigaGuard™树脂适用于两类核心产品的纯化:蛋白制品:单克隆抗体、生长因子;病毒制品:慢病毒、腺相关病毒(AAV)、病毒疫苗。该树脂的设计使目标生物产物无结合通过,实现高纯度与高回收率。其能清除传统纯化工艺难以去除的高残留性HCPs(HR-HCPs),显著提升终产物的纯度、稳定性、疗效与安全性。
| 品名 | 货号 | 规格 |
| LigaTrap LigaGuard 1 ml Packed Column | LT-LG1-1x1mL | 1mL |
| LigaTrap LigaGuard 5ml Packed Column | LT-LG1-1x5mL | 5mL |
| LigaTrap LigaGuard Loose Resin - 5mL | LT-LG1 | 5 mL |
| LigaTrap LigaGuard Loose Resin - 10mL | LT-LG1-10mL | 10 mL |
| LigaTrap LigaGuard Loose Resin - 25mL | LT-LG1-25mL | 25 mL |
| LigaTrap LigaGuard Loose Resin - 50mL | LT-LG1-50mL | 50 mL |
| LigaTrap LigaGuard Loose Resin - 100mL | LT-LG1-100mL | 100 mL |
▍AAVidity
AAVidity填料通过合成亲和配体功能化修饰,可捕获所有血清型的 AAV,提供卓越的结合载量与污染物(宿主细胞蛋白 HCPs 及宿主细胞DNA hcDNA清除能力。其温和洗脱条件在保障 AAV 转导活性的同时,实现高产物回收率。
| 品名 | 货号 | 规格 |
| LigaTrap AAVidity Loose Resin – 1mL | LT-AAV-1mL | 1mL |
| LigaTrap AAVidity Loose Resin – 5mL | LT-AAV-5mL | 5mL |
| LigaTrap AAVidity Prepacked Column – 1mL | LT-AAV-1x1mL | 1x1mL |
| LigaTrap AAVidity Prepacked Column – 5mL | LT-AAV-1x5mL | 1x5mL |
▍IgM Resin
IgM纯化树脂的核心优势包括:
● 全面捕获:同时结合IgM的重链与轻链亚型;
● 零风险:无免疫原性及配体脱落;
● 活性保全:温和洗脱条件保障抗体完整性;
● 经济耐用:消毒再生后可重复使用 ≥100 次;
● 该树脂能高效处理并纯化来自以下样本的单克隆 IgM:细胞培养上清,腹水,杂交瘤,其他重组 IgM 来源。
| 品名 | 货号 | 规格 |
| IgM Microspin Column Kit w/ Buffers | LT-155KIT | KIT-10x0.1mL |
| IgM 1mL Prepacked Column Kit w/ Buffers | LT-155-1mL KIT | KIT-1x1mL |
| IgM 5mL Prepacked Column Kit w/ Buffers | LT-155-5mL KIT | KIT-1x5mL |
| IgM Loose Resin – 5mL | LT-155 | 5mL |
| IgM Loose Resin – 10mL | LT-155-10mL | 10mL |
| IgM Loose Resin – 25mL | LT-155-25mL | 25mL |
| IgM Loose Resin – 50mL | LT-155-50mL | 50mL |
| IgM Loose Resin – 100mL | LT-155-100mL | 100mL |
| IgM Microspin Columns without Buffers | LT-155-MSC | 10x0.1mL |
| IgM Prepacked Column – 1mL | LT-155-1x1mL | 1x1mL |
| IgM Prepacked Column – 5mL | LT-155-1x5mL | 1x5mL |
| IgM Prepacked Columns – 3x1mL | LT-155-3x1mL | 3x1mL |
▍Base Resin
LigaTrap基础纯化树脂可实现高回收率与>95%的纯度,而传统Protein A和Protein G填料的回收率甚至低于检测限。通过优化工艺,该树脂的纯度可进一步提升至99%。
| 品名 | 货号 | 规格 |
| Base Resin Microspin Column Kit w/ Buffers | LT-150KIT | KIT-10x0.1mL |
| Base Resin 1mL Prepacked Column Kit w/ Buffers | LT-150-1mL KIT | KIT-1x1mL |
| Base Resin 5mL Prepacked Column Kit w/ Buffers | LT-150-5mL KIT | KIT-1x5mL |
| Loose Base Resin – 5mL | LT-150 | 5mL |
| Loose Base Resin – 10mL | LT-150-10mL | 10mL |
| Loose Base Resin – 25mL | LT-150-25mL | 25mL |
| Loose Base Resin – 50mL | LT-150-50mL | 50mL |
| Loose Base Resin – 100mL | LT-150-100mL | 100mL |
| Base Resin Microspin Columns without Buffers | LT-150-MSC | 10x0.1mL |
| Base Resin Prepacked Column – 1mL | LT-150-1x1mL | 1x1mL |
| Base Resin Prepacked Column – 5mL | LT-150-1x5mL | 1x5mL |
| Base Resin Prepacked Columns – 3x1mL | LT-150-3x1mL | 3x1mL |
▍Buffers
| 品名 | 货号 | 规格 |
| LigaTrap Elution Buffer | BU-123-FP | 125ml |
| LigaTrap Regeneration Buffer | BU-124-FP | 50ml |
| LigaTrap Neutralization Buffer | BU-125-FP | 15ml |
| LigaTrap Storage Buffer | BU-126-FP | 50 ml |
| LigaTrap Sample Diluent 2.0 | BU-131-FP | 15 ml |
| LigaTrap Equilibration/Wash Buffer 2.0 | BU-132-FP | 250ml |
| LigaTrap IgM Elution Buffer pH 3.8 | BU-133-FP | 125 ml |
| LigaTrap Elution Buffer | BU-123-500-FP | 500ml |
| LigaTrap Regeneration Buffer | BU-124-500-FP | 500 ml |
| LigaTrap Neutralization Buffer | BU-125-250-FP | 250 ml |
| LigaTrap Storage Buffer | BU-126-500-FP | 500 ml |
| LigaTrap Sample Diluent 2.0 | BU-131-250-FP | 250 ml |
| LigaTrap Equilibration/Wash Buffer 2.0 | BU-132-1-FP | 1L |
| LigaTrap IgM Elution Buffer pH 3.8 | BU-133-500-FP | 500ml |

INDOOR Biotechnologies公司专注于室内空气品质、环境科学、过敏和哮喘相关的检测用产品和服务。
Indoor Biotechnologies was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, academic institutions and Fortune 500 companies..
INDOOR Biotechnologies公司的主要产品包括:
Multiplex IgE-QBA™ Kits
MARIA® Kits
ELISA Kits
Purified Allergens
Molecular Reference Standards
Antibodies
Rhinovirus Products
Allergen Standards
RhinixPRO Nasal Filters
Rapid Test and Dust Collection
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://genekam.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="INDOOR Biotechnologies"> INDOOR Biotechnologies
艾美捷科技代理Chemtrade品牌佐剂产品。
Chemtrade专业生产氢氧化铝胶佐剂,用于细菌疫苗、狂犬病疫苗、HPV疫苗、肺炎球菌疫苗、流感疫苗产品等。Chemtrade氢氧化铝胶佐剂主要用于动物疫苗的生产中,作为佐剂与疫苗抗原混合使用。其使用方法通常是将佐剂与抗原以一定比例混合均匀,然后注入动物体内以产生免疫效果。
Chemtrade佐剂特点包括:
(1)粒径小:Chemtrade氢氧化铝胶佐剂的粒径较小,这使得其具有更大的表面积和更强的吸附能力。这一特点使得佐剂能够更有效地与疫苗抗原结合,提高疫苗的免疫效果。
(2)高吸附能力:由于粒径小和表面积大,Chemtrade氢氧化铝胶佐剂能够吸附更多的抗原,从而增强疫苗的免疫原性和稳定性。
(3)低副反应:Chemtrade氢氧化铝胶佐剂在使用过程中表现出较低的副反应,对动物体更为友好,减少了疫苗接种后的不良反应。
(4)品质保障:作为进口佐剂,Chemtrade氢氧化铝胶佐剂经过严格的质检和认证,确保其符合国际标准和要求。同时,国内代理商如河南通商等也提供了稳定的产品供应和优质的服务。
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:13212737804
邮箱:sales@amyjet.com
0.1795